Sculptor Capital’s Asensus Surgical, Inc. ASXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-18,448
Closed -$27K 315
2019
Q4
$27K Buy
18,448
+710
+4% +$2.47K ﹤0.01% 276
2019
Q3
$143K Sell
17,738
-1,339
-7% -$18.2K ﹤0.01% 283
2019
Q2
$337K Buy
19,077
+6,931
+57% +$152K ﹤0.01% 248
2019
Q1
$376K Hold
12,146
﹤0.01% 193
2018
Q4
$357K Sell
12,146
-25,239
-68% -$1.15M ﹤0.01% 202
2018
Q3
$2.82M Buy
+37,385
New +$2.53M 0.02% 126

Other funds holding ASXC

Sculptor Capital's ASXC Position: Q1 2020 in Review

Sculptor Capital sold out of Asensus Surgical, Inc. (ASXC) in Q1 2020, closing a stake of 17,739 shares — an estimated $26K sold.

Sculptor Capital first reported a position in ASXC in Q3 2018 and held it in 6 quarters. The position peaked at $2.82M in Q3 2018. 82 funds tracked by Wall St. Rank hold ASXC as of Q1 2020.

  • Sculptor Capital reported no remaining Asensus Surgical, Inc. position as of Q1 2020 after selling out during the quarter.
  • Sculptor Capital sold 17,739 Asensus Surgical, Inc. shares in Q1 2020, an estimated $26K.
  • Sculptor Capital first reported a position in Asensus Surgical, Inc. in Q3 2018 and held it in 6 quarters.
  • Sculptor Capital's Asensus Surgical, Inc. position peaked at $2.82M in Q3 2018.
  • 82 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q1 2020.

Based on Sculptor Capital's 13F filing for Q1 2020, filed 14 May 2020.